Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NUFIP2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | SPRY1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ZKSCAN8 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | KBTBD2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | VASN | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | ZMYM2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | JAK3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | FEM1C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | TMEM74B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | OR9Q1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |